Hedge Fund and Insider Trading News: David Rosen, David Einhorn, Carl Icahn, Brevan Howard Asset Management, Man Group, Archegos Capital Management, Kinnate Biopharma Inc (KNTE), and More

Page 2 of 2

Focus on Green Metal Supply Chain (Hedge Nordic)
Stockholm (HedgeNordic) – During the summer of last year, one of Atlant Fonder’s funds managed by Mattias Gromark shifted its focus from precious metals to “green” metals in an attempt to capitalize on the green energy transition. Atlant Green Tech Metals has now been subject to additional changes in its fund regulations to sharpen the focus on the supply chain for green metals.

Man Group Hires Two to Lead New Private Credit Strategy (Opalesque)
British hedge fund manager Man Group announced that its private markets investment business Man Global Private Markets hired Jonathan Imundo and Matthew Moniot as co-heads of credit-risk sharing (CRS), a new strategy in its global private markets unit. According to a press release from the world’s largest publicly traded hedge fund, the new CRS strategy is within the firm’s $3.5 billion global private markets unit. Both are from alternative credit manager Elanus Capital Management and will report to Eric Burl, head of global private markets and global co-head of sales and marketing. Jonathan is based in New York, and Matthew is in London.

Morgan Stanley’s Archegos Unwinding Sped Up Trading Probe (Bloomberg Quint)
(Bloomberg) — Morgan Stanley’s role in the unraveling of Bill Hwang’s family office breathed new life into a federal probe examining irregularities in Wall Street’s lucrative market for block trades. U.S. authorities ramped up their investigation into whether big banks and their hedge fund clients broke rules when privately negotiating large stock sales after the blowup at Archegos Capital Management, according to people with knowledge of the matter.

Wednesday 2/16 Insider Buying Report: KNTE, AMG (Nasdaq.com)
At Kinnate Biopharma, a filing with the SEC revealed that on Tuesday, Director Carl L. Gordon purchased 195,700 shares of KNTE, at a cost of $10.17 each, for a total investment of $1.99M. So far Gordon is in the green, up about 9.0% on their purchase based on today’s trading high of $11.08. Kinnate Biopharma is trading up about 8.6% on the day Wednesday. And also on Tuesday, Director Reuben Jeffery III purchased $503,860 worth of Affiliated Managers Group, purchasing 3,500 shares at a cost of $143.96 each. Before this latest buy, Jeffery III bought AMG at 2 other times during the past twelve months, for a total investment of $909,878 at an average of $174.98 per share. Affiliated Managers Group is trading up about 0.6% on the day Wednesday. So far Jeffery III is in the green, up about 1.3% on their purchase based on today’s trading high of $145.89.

Executives Sell Over $50M Of 4 Stocks (Benzinga)
Interactive Brokers Group: The Trade: Interactive Brokers Group, Inc. (IBKR) Chairman Thomas Peterffy disposed a total of 33,000 shares at an average price of $73.61. The insider received around $2.43 million as a result of the transaction. AGNC Investment: The Trade: AGNC Investment Corp. (AGNC) Director, Executive Chairman Gary Kain sold a total of 832,034 shares at an average price of $14.03. The insider received around $11.67 million from selling those shares. Holley: The Trade: Holley Inc. (HLLY) Director James D Coady sold a total of 3,000,000 shares at an average price of $11.20. The insider received $33.6 million as a result of the transaction.

Page 2 of 2